Research at NIBR

Translating genomic information into new medicines

There is no greater privilege than to work towards bettering human health, and no more exciting arena in which to do so than through discovery of new medicines. This is today’s frontier of science.

The interface of the chemical and biological universes is a difficult place to work, worthy of the best minds and most innovative scientists. The paradigm for such science continues to evolve, but new tools are there. For example, we believe that the genome will be functionalized first and best in the context of new medicines. Furthermore, Atomic-level views of proteins provide a more rational base for chemical design than ever before. Finally, clinical translation is facilitated by novel imaging and more precise molecular assays, in order to more appropriately target medicines to individual patient needs.